Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Advanced Malignant Mesothelioma
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Histologically confirmed patients with advanced malignant mesothelioma that who was failure of the first -line systemic therapy

Histologically confirmed patients with advanced malignant mesothelioma that who was failure of the first -line systemic therapy

Tracking Information

NCT #
NCT04290325
Collaborators
Not Provided
Investigators
Principal Investigator: Shun Lu, Prof. Shanghai Chest Hospital